Ignite Creation Date:
2025-12-25 @ 2:42 AM
Ignite Modification Date:
2026-03-25 @ 6:17 AM
Study NCT ID:
NCT05119933
Status:
UNKNOWN
Last Update Posted:
2021-11-15
First Post:
2021-11-11
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 1/2, Study of YL-15293 in Subjects With Advanced Solid Tumors With a KRAS G12C Mutation
Sponsor:
Shanghai YingLi Pharmaceutical Co. Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
YL-15293-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | UNKNOWN | View |